156. レット症候群 [臨床試験数:36,薬物数:49(DrugBank:19),標的遺伝子数:77,標的パスウェイ数:112

Searched query = "Rett syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02023424
(ClinicalTrials.gov)
January 201423/12/2013An Open Label, Exploratory Study to Investigate the Treatment Effect of Glatiramer Acetate on Girls Woth Rett SyndromeAn Open Label, Exploratory Study to Investigate the Treatment Effect og Glatiramer Acetate (Copaxone ®) on Girls Woth Rett SyndromeRett SyndromeDrug: Glatiramer Acetate (Copaxone®)Sheba Medical CenterNULLRecruiting6 Years15 YearsFemale10Phase 1Israel
2NCT02153723
(ClinicalTrials.gov)
August 201326/5/2014Pharmacological Treatment of Rett Syndrome With Glatiramer Acetate (Copaxone)Pharmacological Treatment of Rett Syndrome With Glatiramer Acetate (Copaxone)Rett SyndromeDrug: Glatiramer AcetateMontefiore Medical CenterRett Syndrome Research TrustCompleted10 YearsN/AFemale10Phase 2United States